) [153]. This method is now not scalable because it depends on read more high-priced startup substrates that may be employed to supply psilocybin in more affordable chemical synthesis methodologies. A methodology for de novo creation of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae, When he commenced administering psilocybin to